
Join to view full profile
5841 S Maryland AveChicago, IL 60637
Phone+1 888-824-0200
Fax+1 773-702-3163
Dr. Smith is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sonali Smith is an oncologist in Chicago, IL and is affiliated with University of Chicago Medical Center. She received her medical degree from Northwestern University Feinberg School of Medicine and has been in practice 23 years. She specializes in hematologic oncology and is experienced in Hodgkin and non-Hodgkin lymphoma.
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 1998 - 2001
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1994 - 1997
Northwestern University The Feinberg School of MedicineClass of 1994
Certifications & Licensure
IL State Medical License 1997 - 2029
WI State Medical License 2022 - 2023
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
- Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid Tumors
- CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Publications & Presentations
PubMed
- 2 citationsHistorical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses.Jamie E Flerlage, Dennis A Eichenauer, Michael Fuchs, Sylvia Hartmann, Hans T Eich
Blood Advances. 2026-08-11 - Corrigendum to 'Clinical Practice Recommendations for Hematopoietic Cell Transplantation.' Transplant Cell Ther. 2024 Sep;30(9):832-843.Madiha Iqbal, Ambuj Kumar, Peter Dreger, Julio Chavez, Craig S Sauter
Transplantation and Cellular Therapy. 2026-06-01 - 4 citationsConsensus recommendations from the 2024 International Follicular Lymphoma Scientific Workshop.Reid Merryman, Sarah C Rutherford, Stephen Ansell, Philippe Armand, John P Leonard
Blood Advances. 2026-03-10
Journal Articles
- CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s LymphomaSonali (Mehta) Smith, MD, The New England Journal of Medicine
- Five-Year Follow-up of Lenalidomide plus Rituximab as Initial Treatment for Mantle Cell LymphomaJia Ruan, Jakub Svoboda, John P Leonard, Sonali M Smith, Morton Coleman, Richard R Furman, Blood
Abstracts/Posters
- A Phase 2 Study of the Dual SYK/JAK Inhibitor Cerdulatinib Demonstrates Good Tolerability and Clinical Response in Relapsed/Refractory Peripheral T-Cell Lymphoma and C...Sonali M. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- PET-Directed Therapy for Patients with Limited-Stage Diffuse Large B-Cell Lymphoma - Results of Intergroup Nctn Study S1001Sonali M. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Beyond PD-1: Investigating the Therapeutic Potential of TIGIT Blockade in DLBCLSonali M. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Checkpoint Blockade Therapy May Sensitize Hodgkin Lymphoma to Subsequent Therapy2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Five-Year Outcomes of SWOG S0: A Randomized Phase II US Intergroup Study of R-HCVAD Vs. R-Bendamustine Followed By Autologous Stem Cell Transplant for Patients with Ma...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Checkpoint Blockade Therapy May Sensitize Aggressive and Indolent Non-Hodgkin Lymphoma to Subsequent Therapy2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
What Would “The Pitt: Oncology” Really Look Like?August 24th, 2026
UChicago Medicine Highlights Research, Leadership, Clinical Advances at ASCO 2026June 11th, 2026
UChicago Medicine Launches Miller Family Center for Rare Blood Cancers Thanks to Philanthropic GiftDecember 10th, 2025
Grant Support
- Developing an Oncology Workforce for the 21st CenturyUNIVERSITY OF CHICAGO2010–2025
Committees
- Member, Committee on Appropriateness Criteria, Expert Panel on Radiation Oncology - Lymphoma, American College of Radiology 2015 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: